Sutureless aortic valve bioprothesis '3F/ATS Enable' - 4.5 Years of a single-centre experience

Kardiologia Polska

Volumn 67, Issue 8, 2009, Pages 956-963

  Sadowski, Jerzy ^a   Kapelak, Bogusław ^a   Pfitzner, Roman ^a   Bartuś, Krzysztof ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

'Enable' aortic bioprosthetic valve; Equine pericardium; Nitinol; Sutureless implantation

Indexed keywords

GLUTARALDEHYDE;

ADULT; AGED; AORTA CLAMPING; AORTA VALVE DISEASE; AORTA VALVE PROSTHESIS; ARTICLE; BIOPROSTHESIS; CARDIOPLEGIA; CLINICAL ARTICLE; COMORBIDITY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INDUCED HYPOTHERMIA; MALE; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; OPERATION DURATION; SURGICAL TECHNIQUE;

EID: 72449135300     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Raport Krajowego Rejestru Operacji Kardiochirurgicznych, KROKPolkard, Kardiochirurgia Polska 2008. Klub Kardiochirurgów Polskich.
2. Sadowski J, Wierzbicki K, Cieśla-Dul M. Nowe technologie, niewydolność serca - znane i poznawane wyzwania w leczeniu operacyjnym wad lewego ujścia tȩtniczego. Kardiologia po Dyplomie 2008; 1: 30-39
3. Sadowski J, Kapelak B, Wróbel K. Techniki chirurgicznego leczenia wad zastawki aortalnej i patologii aorty wstȩpuja̧cej. In: Tracz W, Podolec P, Hoffman P. (eds.). Echokardiografia praktyczna. Medycyna Praktyczna, Kraków 2005; II: 277-289
4. Varadarajan P, Kapoor N, Bansal RC, et al. Survival of elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement. Results from a cohort of 277 patients aged > or = 80 years. Eur J Cardiothorac Surg 2006; 30: 722.
5. Kuduvalli M, Grayson AD, Au J, et al. A multi-center additive and logistic risk model for in-hospital mortality following aortic valve replacement. Eur J Cardiothorac Surg 2007; 31: 607-613 (Pubitemid 46400490)
6. Bartuś K, Sadowski J, Kapelak B, et al. Pierwsze użycie bezszwowej zastawki Enable u ludzi. Obserwacja roczna. Kardiochir i Torakochir Pol 2006; 3 (Supl. 1.): 45-46
7. Sadowski J, Kapelak B, Bartuś K, et al. First human use of the Enable aortic valve bioprosthesis: sutureless implantation of a stented pericardial valve. 3rd Biennial Meeting of the Society for Heart Valve Diseases, Vancouver 2005. Abstract P175.
8. Trybowski G, Olejniczak P, Sadowski J. Bezszwowa biologiczna zastawka aortalna 3F. In: Podolec P, Tracz W, Hoffman P, et al. (eds.). Echokardiografia praktyczna. Medycyna Praktyczna, Kraków 2006; IV: 289-292
9. Sadowski J, Kapelak B, Bartuś K, et al. Stentless 3F Therapeutics Aortic Bioprosthesis - a new alternative to aortic replacement. Acta Cardiol 2004; 59: 231-232
10. Cox H, Ad N, Myers K, et al. Tubular heart valves: a new tissue design - preclinical eveluation of the 3F aortic bioprosthesis. J Thorac Cardiovasc Surg 2005; 130: 520-527 (Pubitemid 41074187)
11. Martens S, Ploss A, Sirat S, et al. Sutureless aortic valve replacement with the 3F Enable aortic bioprosthesis. Ann Thorac Surg 2009; 87: 1914-1918
12. Wendt D, Thielmann M, Buck T, et al. First clinical experiences and 1-year follow-up with the sutureless 3F-Enable aortic valve prosthesis. Eur J Cardiothorac Surg 2008; 33: 542-547
13. Leyh R, Yildirim C, Buck T, et al. Early single-center experience with 3F-Enable aortic valve bioprosthesis. Herz 2006; 31: 423-428 (Pubitemid 44385426)
14. Magovern JJr. Invited commentary (to: 11.). Ann Thorac Surg 2009; 87: 1917-1918
15. Harringer W, Schmitz C, Sadowski J, et al. The trilogy sutureless aortic valve system: early experience with a modular, tri-lobal bovine pericardium valve technology. Das Magazin zur 36. Jahrestagung der Deutschen Gesellschaft fur Thorax-Herz und Gefasschirurgie, Hamburg 2007; 16.
16. Wilczek K, Chodór P, Przybylski R, et al. Przezcewnikowe implantacje zastawek w objawowej stenozie aortalnej u chorych niebȩda̧cych kandydatami do leczenia operacyjnego - wspólne zabiegi kardiologów i kardiochirurgów. Kardiochir i Torakochir Pol 2008; 5: 386-396
17. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007; 116 (Suppl. 11): 1240-1245 (Pubitemid 47480797)
18. Wendt D, Eggebrecht H, Kahlert P, et al. Successful transapical aortic valve implantation four weeks before 97th birthday. Interact Cardiovasc Thorac Surg 2009; 8: 684-686
19. Cieśla-Dul M, Pfitzner R, Drwiła R, et al. Low ejection fraction as risk factor after aortic valve replacement. Przegl Lek 2004; 61: 579-584